Directed evolution of a carbonyl reductase LsCR for the enantioselective synthesis of (1S)-2-chloro-1-(3,4-difluorophenyl) ethanol.
Carbonyl reductase
Catalytic performance
Computer-aided design
Protein engineering
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
09
05
2022
revised:
22
06
2022
accepted:
23
06
2022
pubmed:
12
7
2022
medline:
16
8
2022
entrez:
11
7
2022
Statut:
ppublish
Résumé
Traditional screening methods of enzyme engineering often require building large mutant libraries to screen for potentially beneficial sites, which are often time-consuming and labor-intensive with low mining efficiency. In this study, a novel enzyme engineering strategy was established to modify carbonyl reductase LsCR for the synthesis of (1S)-2-chloro-1-(3,4-difluorophenyl) ethanol ((S)-CFPL), which is a key intermediate of anticoagulant drug ticagrelor. The strategy was developed by combining HotSpot, FireProt and multiple sequence alignment, resulting in the construction of a "small and smart" mutant library including 10 mutations. Among them, 5 mutations were positive, resulting in a 50% mining accuracy of beneficial sites. Finally, a highly active mutant LsCR
Identifiants
pubmed: 35816872
pii: S0045-2068(22)00397-2
doi: 10.1016/j.bioorg.2022.105991
pii:
doi:
Substances chimiques
Ethanol
3K9958V90M
Alcohol Oxidoreductases
EC 1.1.-
2-Propanol
ND2M416302
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105991Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.